- Investing Ideas
- /
- Healthcare Biotech Breakthroughs
Healthcare Biotech Breakthroughs
Results
16
0 new
Companys with strong funding and high growth potential
16 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
QLINES | SEK 4.78 | 0% | -81.0% | SEK 380.9m | SEK 14.66 | PS60.2x | E57.4% | n/a | ||
BELL | UK£0.12 | 0% | -68.0% | UK£20.2m | n/a | PS32.6x | E113.4% | n/a | ||
0IFR | US$1.24 | -3.1% | 75.5% | US$26.1m | US$6.41 | PS1.4x | E71.2% | n/a | ||
RUA | UK£0.12 | 6.5% | -21.0% | UK£7.6m | n/a | PS3.5x | E98.2% | n/a | ||
IMMNOS | SEK 34.30 | 0% | -44.7% | SEK 551.8m | SEK 119.59 | PS581.4x | E76.7% | n/a | ||
0H9M | NOK 14.33 | 0% | -9.1% | NOK 1.2b | NOK 23.80 | PS4.5x | E112.6% | 11.5% | ||
GBTP | €17.04 | 0% | 6.4% | €212.1m | €20.91 | PB0.5x | E106.7% | 3.1% | ||
0QMX | CHF 4.13 | 0% | -53.3% | CHF 50.6m | n/a | PS1x | E96.2% | 0% | ||
0I0L | €4.11 | 0% | n/a | €15.5m | €3.10 | PB0.4x | E133.9% | 0% | ||
0DYQ | €12.65 | 0% | -30.2% | €172.3m | €17.27 | PB0.6x | E56.1% | n/a | ||
0MFU | €1.06 | -1.3% | -42.4% | €163.8m | €1.60 | PB0.4x | E102.6% | n/a | ||
0NES | €0.92 | -4.7% | 0.4% | €169.0m | €1.05 | PB1.1x | E78.0% | 7.6% | ||
0HKD | US$14.43 | 5.8% | 181.5% | US$617.1m | US$16.22 | PS3.6x | E79.4% | n/a | ||
0H8I | US$1.77 | -19.6% | -36.9% | US$173.5m | US$6.26 | PB3.8x | E130.6% | n/a | ||
MEDXZ | CHF 9.43 | -2.1% | -58.8% | CHF 386.7m | CHF 24.87 | PB0.8x | E59.6% | 5.3% | ||
SPEC | UK£0.52 | -10.7% | -40.6% | UK£52.9m | n/a | PB0.5x | E118.5% | 0% |
Page 1 of 1